Stocks News

LAST PRICE
499.3000
TODAY'S CHANGE (%)
Trending Up10.0600 (2.0563%)

Bid / Lots
476.0000/ 2
Ask / Lots
560.0000/ 2
Open / Previous Close
484.0300 / 489.2400
Day Range
Low 484.0300
High 500.4800
52 Week Range
Low 372.5000
High 583.3900
Volume
529,834
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 4, 2024
- Press Release: IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:35PM ET on Thursday Apr 04, 2024 by Dow Jones
  4:35PM ET on Thursday Apr 04, 2024 by Dow Jones
  Companies Mentioned: IDXX
  
  IDEXX Laboratories to Release 2024 First Quarter Financial Results
  WESTBROOK, Maine--(BUSINESS WIRE)--April 04, 2024--
  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
- IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:30PM ET on Thursday Apr 04, 2024 by Business Wire
  4:30PM ET on Thursday Apr 04, 2024 by Business Wire
  Companies Mentioned: IDXX
  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
- IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:30PM ET on Thursday Apr 04, 2024 by Dow Jones
  4:30PM ET on Thursday Apr 04, 2024 by Dow Jones
  Companies Mentioned: IDXX
  WESTBROOK, Maine--(BUSINESS WIRE)--April 04, 2024--
  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Yesterday
- UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
- Morgan Stanley Adjusts DexCom's Price Target to $132 From $122, from 11:08AM ET on Friday Apr 26, 2024 by MT Newswires
  11:08AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
- Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144, from 10:53AM ET on Friday Apr 26, 2024 by MT Newswires
  10:53AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Raymond James Adjusts DexCom Price Target to $160 From $151, from 10:25AM ET on Friday Apr 26, 2024 by MT Newswires
  10:25AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: DXCM
- Align Technology to Buy Back $150 Million in Shares, from 10:05AM ET on Friday Apr 26, 2024 by MT Newswires
  10:05AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: ALGN
- Align Technology Announces $150 Million Open Market Repurchase, from 8:30AM ET on Friday Apr 26, 2024 by Business Wire
  8:30AM ET on Friday Apr 26, 2024 by Business Wire
  Companies Mentioned: ALGN
Apr 25, 2024
- DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours, from 4:43PM ET on Thursday Apr 25, 2024 by MT Newswires
  4:43PM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: DXCM
- -- Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27, from 4:05PM ET on Thursday Apr 25, 2024 by MT Newswires
  4:05PM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: DXCM
- -- Earnings Flash (DXCM) DEXCOM Posts Q1 Revenue $921M, vs. Street Est of $910.9M, from 4:04PM ET on Thursday Apr 25, 2024 by MT Newswires
  4:04PM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: DXCM

IDEXX Laboratories Inc
NASDAQ:IDXXUnited States

Search Criteria

Apr 4, 2024

Press Release: IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:35PM ET on Thursday Apr 04, 2024 by Dow Jones

IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:30PM ET on Thursday Apr 04, 2024 by Business Wire

IDEXX Laboratories to Release 2024 First Quarter Financial Results, from 4:30PM ET on Thursday Apr 04, 2024 by Dow Jones

Peers Headlines

Yesterday

UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires

Morgan Stanley Adjusts DexCom's Price Target to $132 From $122, from 11:08AM ET on Friday Apr 26, 2024 by MT Newswires

Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires

Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144, from 10:53AM ET on Friday Apr 26, 2024 by MT Newswires

Raymond James Adjusts DexCom Price Target to $160 From $151, from 10:25AM ET on Friday Apr 26, 2024 by MT Newswires

Align Technology to Buy Back $150 Million in Shares, from 10:05AM ET on Friday Apr 26, 2024 by MT Newswires

Align Technology Announces $150 Million Open Market Repurchase, from 8:30AM ET on Friday Apr 26, 2024 by Business Wire

Apr 25, 2024

DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours, from 4:43PM ET on Thursday Apr 25, 2024 by MT Newswires

-- Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27, from 4:05PM ET on Thursday Apr 25, 2024 by MT Newswires

-- Earnings Flash (DXCM) DEXCOM Posts Q1 Revenue $921M, vs. Street Est of $910.9M, from 4:04PM ET on Thursday Apr 25, 2024 by MT Newswires